InterAx
Agent22Agent Readiness: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 41.AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.
About
InterAx Biotech develops novel therapies by translating complex biology into breakthrough medicines using its Deep Signal™ platform. This platform integrates mathematical modeling, experimental methods, and machine learning to decipher cell signaling language, enabling the design of highly efficacious small molecule drug candidates targeting GPCRs. InterAx serves to generate high-efficacy leads and improve drug profiles by understanding disease impact before pre-clinical trials.
Key facts
At-a-glance profile data
- Website
- interaxbiotech.com
- Headquarters
- Schlieren, Switzerland
- Founded
- 2016
- Employees
- 15
- Total funding
- $3M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 25 Oct 2019 | Funding Round | $3M | - |
Tech stack
Detected on interaxbiotech.com, last scanned 24 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Rank Math
- CMS / Builders
- WordPress
- Hosting
- OVHcloud
- Email provider
- Microsoft 365
Frequently asked
How much funding has InterAx raised?
InterAx has raised a total of $3M in funding. The most recent round on record is Funding Round.
How many employees does InterAx have?
InterAx has approximately 15 people on record.